12.17.19
OmniActive Health Technologies has entered into an exclusive distribution partnership in China with Shanghai Prochin. Through its distribution reach and relationships with key brands, Shanghai Prochin will market Lutemax 2020 Lutein and Zeaxanthin Isomers to all segments of the nutraceutical industry in China.
The global nutrition supplement market is expected to surge to $220.3 billion by 2022, with China expected to reach $40 billion by 2023 growing at a CAGR of 14% (Zion Market Research, 2019; Roland Berger, 2019). Moreover, it has been reported that China may soon become the most significant nutritional supplement market in the world, currently a title held by the U.S. (Roland Berger, 2019).
“China’s 1.4 billion people account for the highest general population on the globe, and with screen time on the rise as well as an increase in life expectancy and changes in diet, the clinically-studied, globally-recognized vision and cognitive health and performance benefits of Lutemax 2020 will fill a much needed nutritional gap,” said Johan Kamphuis, president, global business, OmniActive Health Technologies. “We stand confident that combining Shanghai Prochin’s capabilities and OmniActive’s expertise in innovation and technologies will ensure sustainable growth in this key market.”
The global nutrition supplement market is expected to surge to $220.3 billion by 2022, with China expected to reach $40 billion by 2023 growing at a CAGR of 14% (Zion Market Research, 2019; Roland Berger, 2019). Moreover, it has been reported that China may soon become the most significant nutritional supplement market in the world, currently a title held by the U.S. (Roland Berger, 2019).
“China’s 1.4 billion people account for the highest general population on the globe, and with screen time on the rise as well as an increase in life expectancy and changes in diet, the clinically-studied, globally-recognized vision and cognitive health and performance benefits of Lutemax 2020 will fill a much needed nutritional gap,” said Johan Kamphuis, president, global business, OmniActive Health Technologies. “We stand confident that combining Shanghai Prochin’s capabilities and OmniActive’s expertise in innovation and technologies will ensure sustainable growth in this key market.”
